Last deal

$190.M

Amount

Venture - Series Unknown

Stage

10.01.2022

Date

3

all rounds

$381.M

Total amount

General

About Company
Maze Therapeutics translates genetic insights into new medicines.

Industry

Sector :

Subsector :

Also Known As

Maze

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company uses a biotechnology platform that combines large-scale human genetics data, functional genomics, and drug discovery approaches to identify modifier genes that provide protection against diseases. This approach enables the development of novel therapies that mimic protective mutations. Maze Therapeutics has a team of experienced scientific pioneers, company builders, and biotech industry leaders working towards this vision.
Contacts